{
  "markdown": " BD Totalys MultiProcessor \\| CISA A A ( Lock ) or[\\#protect2024](/protect2024)  Search Menu Close[Faith\\-Based Community](/audiences/faith-based-community) [High\\-Risk Communities](/audiences/high-risk-communities)* Resources \\& Tools[Resources \\& Tools](/resources-tools) [All Resources \\& Tools](/resources-tools/all-resources-tools)* News \\& Events[News \\& Events](/news-events) [Cybersecurity Alerts \\& Advisories](/news-events/cybersecurity-advisories)[Benefits \\& Perks](/careers/benefits-perks)[Resume \\& Application Tips](/careers/resume-application-tips)[Students \\& Recent Graduates](/students-recent-graduates-employment-opportunities)[Divisions \\& Offices](/about/divisions-offices)[\\#protect2024](/protect2024) 2. [News \\& Events](/news-events)4. [ICS Medical Advisory](/news-events/cybersecurity-advisories?f%5B0%5D=advisory_type%3A96) ICS Medical AdvisoryBD Totalys MultiProcessor========================= Last Revised October 04, 2022 Alert Code ICSMA\\-22\\-277\\-011\\. EXECUTIVE SUMMARY---------------------* **CVSS v3 6\\.6*** **ATTENTION:**  Low attack complexity* **Vendor:**  Becton, Dickinson and Company (BD)* **Equipment:**  Totalys MultiProcessor* **Vulnerability:**  Use of Hard\\-coded Credentials2\\. RISK EVALUATION------------------- Successful exploitation of this vulnerability could allow an attacker to access, modify, or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI), and personally identifiable information (PII).3\\. TECHNICAL DETAILS---------------------### 3\\.1 AFFECTED PRODUCTS The following BD products and versions are affected:* BD Totalys MultiProcessor: All versions 1\\.70 and prior### 3\\.2 VULNERABILITY OVERVIEW#### 3\\.2\\.1 [USE OF HARD\\-CODED CREDENTIALS CWE\\-798](https://cwe.mitre.org/data/definitions/798.html) The affected product uses hard\\-coded credentials, which could allow an attacker to access, modify, or delete sensitive information including ePHI, PHI, and PII. To exploit this vulnerability, a threat actor would need physical or network access to the system and would need to bypass any additional security controls.[CVE\\-2022\\-40263](http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2022-40263)  has been assigned to this vulnerability. A CVSS v3 base score of 6\\.6 has been assigned; the CVSS vector string is ( [AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:L](https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:L)  ).### 3\\.3 BACKGROUND* **CRITICAL INFRASTRUCTURE SECTORS:**  Healthcare and Public Health* **COUNTRIES/AREAS DEPLOYED:**  Worldwide* **COMPANY HEADQUARTERS LOCATION:**  United States### 3\\.4 RESEARCHER BD reported this vulnerability to CISA.4\\. MITIGATIONS--------------- According to BD, this vulnerability is scheduled to be remediated in the BD Totalys MultiProcessor version 1\\.71 software release expected in fourth quarter 2022\\. BD recommends the following compensating controls for users with versions of the BD Totalys MultiProcessor using hard\\-coded credentials:* Ensure physical access controls are in place; only authorized end\\-users should have access to the BD Totalys MultiProcessor.* If the BD Totalys MultiProcessor must be connected to a network, ensure industry standard network security policies and procedures are followed. For additional information, users should see BD\u2019s [security bulletin](https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/bd-totalys-multiprocessor-hardcoded-credentials)  . CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability these vulnerabilities. CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures. CISA also provides a section for [control systems security recommended practices](https://us-cert.cisa.gov/ics/Recommended-Practices)  on the ICS webpage at [cisa.gov/ics](https://cisa.gov/ics)  . Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with [Defense\\-in\\-Depth Strategies](https://us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf)  . Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at [cisa.gov/ics](https://cisa.gov/ics)  in the technical information paper, [ICS\\-TIP\\-12\\-146\\-01B\\-\\-Targeted Cyber Intrusion Detection and Mitigation Strategies](https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B)  . Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents. No known public exploits specifically target this vulnerability. This vulnerability is not exploitable remotely. This product is provided subject to this [Notification](/notification \"Follow link\")  and this [Privacy \\& Use](/privacy-policy \"Follow link\")  policy.Vendor------* Becton, Dickinson and Company (BD)-------------------------- [product survey](https://www.surveymonkey.com/r/CISA-cyber-survey?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-277-01)  ; Related Advisories------------------ Jul 18, 2024 ICS Medical Advisory \\| ICSMA\\-24\\-200\\-01### [Philips Vue PACS](/news-events/ics-medical-advisories/icsma-24-200-01) Jun 11, 2024 ICS Medical Advisory \\| ICSMA\\-24\\-163\\-01### [MicroDicom DICOM Viewer](/news-events/ics-medical-advisories/icsma-24-163-01) May 30, 2024 ICS Medical Advisory \\| ICSMA\\-24\\-151\\-02### [Baxter Welch Allyn Connex Spot Monitor](/news-events/ics-medical-advisories/icsma-24-151-02) May 30, 2024 ICS Medical Advisory \\| ICSMA\\-24\\-151\\-01### [Baxter Welch Allyn Configuration Tool](/news-events/ics-medical-advisories/icsma-24-151-01)* [Resources \\& Tools](/resources-tools)* [News \\& Events](/news-events)[Cybersecurity \\& Infrastructure Security Agency](/ \"Go to the Cybersecurity & Infrastructure Security Agency homepage\")[1\\-844\\-Say\\-CISA](tel:1-844-Say-CISA) * [Equal Opportunity \\& Accessibility](/oedia \"Equal Opportunity & Accessibility\")",
  "cves": [
    "CVE-2022-40263"
  ],
  "techniques": [],
  "advisory": "icsma-22-277-01",
  "title": "BD Totalys MultiProcessor | CISA",
  "source": "ics-medical-advisories",
  "id": "fa687dd57a4dbdbd553f66c04abe8abeb3ec89c51203fcf8f9492cdc8f1cecda"
}